Panel Discussion: Tips and tricks for translating academic technologies into commercial products

Timeslot: Thursday, April 28, 2022 - 1:00pm to 2:30pm
Room: Waterview Ballroom, Ground


This is an interactive panel that includes representation from companies (large and small), regulatory affairs, and investors spanning a broad range of biomaterials applications (drug delivery, ophthalmic biomaterials, nanomaterials, tissue engineering, etc.). Panelists will discuss challenges with translating academic technologies to viable commercial products, particularly issues associated with de-risking and translating basic research. Discussion will also include how biomaterials products and technologies are valued, including considerations of reimbursement rates. The balance and trade-offs between innovation and translational value will be highlighted as well as the challenges associated with the sometimes divergent values and priorities of academia versus industry.


Abstracts will be available for download on April 27, 2022.

  • Amelia Zellander, PhD, BioLattice

  • Henry Brem, Johns Hopkins University SOM

  • Kwame Ulmer, Wave- maker Three-Sixty Health

  • G Lawrence Thatcher, TESco Associates